Literature DB >> 12384787

Linkage of one gene for familial glucocorticoid deficiency type 2 (FGD2) to chromosome 8q and further evidence of heterogeneity.

Emmanuelle Génin1, Angela Huebner, Christine Jaillard, Armelle Faure, Georges Halaby, Nurçin Saka, Adrian J L Clark, Philippe Durand, Martine Bégeot, Danielle Naville.   

Abstract

In several cases of familial glucocorticoid deficiency (FGD), referred to as FGD type 1, mutations have been described in the coding exon of the adrenocorticotropin receptor (melanonocortin receptor type 2, MC2R) gene. However, for the majority of cases (FGD type 2), no mutations were found in this gene. In the more informative families, the involvement of the MC2R locus could be excluded by linkage or sequencing analysis and, as there was no obvious candidate gene, a genome linkage scan was performed. Fourteen families were studied in this report. Evidence of linkage was found with markers on chromosome 8q in three out of the 14 families (maximum heterogeneity LOD score of 2.81 at D8S1763). These three families were consanguineous and the gene could be located by homozygosity mapping between markers D8S285 and D8S1718 in a 8.8-cM region. No potential candidate genes were apparent in the region. Linkage to this region could be excluded in some families from our sample giving highly negative LOD scores with the markers of the region. This result suggests that at least one other gene, located on a different region, must be responsible for FGD in these families and provides new evidence of genetic heterogeneity of this disorder.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12384787     DOI: 10.1007/s00439-002-0806-3

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  5 in total

1.  Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis.

Authors:  Dai Chida; Shinichi Nakagawa; So Nagai; Hiroshi Sagara; Harumi Katsumata; Toshihiro Imaki; Harumi Suzuki; Fumiko Mitani; Tadashi Ogishima; Chikara Shimizu; Hayato Kotaki; Shigeru Kakuta; Katsuko Sudo; Takao Koike; Mitsumasa Kubo; Yoichiro Iwakura
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-07       Impact factor: 11.205

2.  Characterization of novel StAR (steroidogenic acute regulatory protein) mutations causing non-classic lipoid adrenal hyperplasia.

Authors:  Christa E Flück; Amit V Pandey; Bernhard Dick; Núria Camats; Mónica Fernández-Cancio; María Clemente; Miquel Gussinyé; Antonio Carrascosa; Primus E Mullis; Laura Audi
Journal:  PLoS One       Date:  2011-05-27       Impact factor: 3.240

Review 3.  ACTH Receptor (MC2R) Specificity: What Do We Know About Underlying Molecular Mechanisms?

Authors:  Davids Fridmanis; Ance Roga; Janis Klovins
Journal:  Front Endocrinol (Lausanne)       Date:  2017-02-06       Impact factor: 5.555

4.  Can Digenic, Tri-Allelic Inheritance of Variants in STAR and CYP11A1 Give Rise to Primary Adrenal Insufficiency? A Case Report.

Authors:  Naseer Ali; Avinaash Vickram Maharaj; Federica Buonocore; John C Achermann; Louise A Metherell
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-28       Impact factor: 5.555

5.  Nonclassic lipoid congenital adrenal hyperplasia masquerading as familial glucocorticoid deficiency.

Authors:  Louise A Metherell; Danielle Naville; George Halaby; Martine Begeot; Angela Huebner; Gudrun Nürnberg; Peter Nürnberg; Jane Green; Jeremy W Tomlinson; Nils P Krone; Lin Lin; Michael Racine; Dan M Berney; John C Achermann; Wiebke Arlt; Adrian J L Clark
Journal:  J Clin Endocrinol Metab       Date:  2009-09-22       Impact factor: 5.958

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.